All stacksAnti-Aging stack

The Fountain Protocol

Core longevity stack for cellular rejuvenation. Three tiers, from R810, each listed with what is in it, why the compounds are combined, and who should not use it.

06

The Fountain Protocol

Core longevity stack for cellular rejuvenation

Safe
Anti-AgingSimultaneous

Epithalon activates telomerase to slow cellular ageing at the DNA level. NAD+ restores mitochondrial energy production that naturally declines with age. GHK-Cu reverses dermal collagen loss and modulates over 4,000 genes involved in repair and anti-inflammation. At the Premium tier, Thymalin and Thymosin Alpha-1 restore thymic immune function, one of the most important and underaddressed longevity pathways.

TierIncludesPrice

Tap a tier to choose it

Safety Note

A well-studied combination targeting multiple distinct hallmarks of ageing simultaneously. NAD+ and GHK-Cu synergise through cellular energy and structural repair pathways with no adverse interactions identified.

Contraindications — Do Not Use If:

Active cancer or strong family history of cancer. Epithalon activates telomerase and requires oncology consultation before use.

Wilson's disease or copper metabolism disorders. GHK-Cu is contraindicated.

Immunosuppressant medications (cyclosporine, tacrolimus, etc.). Premium tier immune compounds may counteract immunosuppressive therapy.

Post-organ transplant patients.

Pregnancy and breastfeeding.

Under 18 years of age.

Pregnancy and breastfeeding. None of the stacks in this guide have been evaluated for safety during pregnancy.

Under 18 years of age. Not suitable for minors.

Active cancer or personal history of cancer. Consult an oncologist before using any GH-stimulating, telomerase-activating, or immune-modulating peptides.

Type 1 or Type 2 diabetes on medication. GH secretagogues and GLP-1 agonists affect blood glucose; medical supervision is required.

Immunosuppressant medications. Thymosin Alpha-1, Thymalin, and Epithalon actively stimulate immune function and may counteract immunosuppressive therapy.

Wilson's disease or copper metabolism disorders. GHK-Cu and AHK-Cu are contraindicated.

Medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome. GLP-1 receptor agonists are contraindicated.

History of pancreatitis. GLP-1 receptor agonists carry a risk of pancreatitis.

Athletes subject to WADA anti-doping testing. TB-500, GH secretagogues, and HGH Somatropin are all prohibited substances.

All peptides on this page are for research purposes only and are not intended for human or veterinary use.

All products are for research purposes only and are not intended for human or veterinary use.